Analysis of gene expression in cancer cell lines identifies candidate markers for pancreatic tumorigenesis and metastasis
- PMID: 15305381
- DOI: 10.1002/ijc.20376
Analysis of gene expression in cancer cell lines identifies candidate markers for pancreatic tumorigenesis and metastasis
Abstract
Pancreatic cancer is a highly aggressive type of malignancy and the prognosis for disease presenting typically at a late stage is extremely poor. A comprehensive understanding of its molecular genetics is required in order to develop new approaches to clinical management. To date, serial analysis of gene expression and more recently oligo/cDNA microarray technologies have been employed in order to identify genes involved in pancreatic neoplasia that can be developed as diagnostic markers and drug targets for this dismal disease. This study describes the expression profile obtained from 20 pancreatic cell lines using cDNA microarrays containing 9,932 human gene elements. Numerous genes were identified as being differentially expressed, some of which have been previously implicated in pancreatic adenocarcinoma (S100P, S100A4, prostate stem cell antigen, lipocalin 2, claudins 3 and 4, trefoil factors 1 and 2) as well as several novel genes. The differentially expressed genes identified are involved in a variety of cellular functions, including control of transcription, regulation of the cell cycle, proteolysis, cell adhesion and signaling. Validation of our array results was performed by exploring the SAGEmap database and by immunohistochemistry for a selection of 4 genes that have not previously been studied in pancreatic cancer: anterior gradient 2 homologue (Xenopus laevis), insulin-like growth factor binding protein 3 and 4 and Forkhead box J1. Immunostaining was performed using pancreas-specific tissue microarrays containing core biopsies from 305 clinical specimens. In addition, using statistical group comparison and hierarchical clustering, a selection of genes was identified that may be linked to the site of metastasis from which these cell lines were isolated.
Copyright 2004 Wiley-Liss, Inc.
Similar articles
-
Relationships and differentially expressed genes among pancreatic cancers examined by large-scale serial analysis of gene expression.Cancer Res. 2002 Feb 1;62(3):819-26. Cancer Res. 2002. PMID: 11830538
-
Highly expressed genes in pancreatic ductal adenocarcinomas: a comprehensive characterization and comparison of the transcription profiles obtained from three major technologies.Cancer Res. 2003 Dec 15;63(24):8614-22. Cancer Res. 2003. PMID: 14695172
-
Molecular profiling of pancreatic adenocarcinoma and chronic pancreatitis identifies multiple genes differentially regulated in pancreatic cancer.Cancer Res. 2003 May 15;63(10):2649-57. Cancer Res. 2003. PMID: 12750293
-
Confirmation of DNA microarray-derived differentially expressed genes in pancreatic cancer using quantitative RT-PCR.Pancreatology. 2009;9(5):577-82. doi: 10.1159/000212084. Epub 2009 Aug 4. Pancreatology. 2009. PMID: 19657213 Review.
-
Microarray-based gene expression profiling in pancreatic ductal carcinoma: status quo and perspectives.Int J Colorectal Dis. 2004 Sep;19(5):401-13. doi: 10.1007/s00384-003-0563-3. Epub 2004 Jan 24. Int J Colorectal Dis. 2004. PMID: 14745573 Review.
Cited by
-
Claudins-Promising Biomarkers for Selected Gastrointestinal (GI) Malignancies?Cancers (Basel). 2023 Dec 28;16(1):152. doi: 10.3390/cancers16010152. Cancers (Basel). 2023. PMID: 38201579 Free PMC article. Review.
-
The Lcn2-engineered HEK-293 cells show senescence under stressful condition.Iran J Basic Med Sci. 2015 May;18(5):459-64. Iran J Basic Med Sci. 2015. PMID: 26124931 Free PMC article.
-
Identifying Biomarkers and Drug Targets Using Systems Biology Approaches for Pancreatic Cancer.Pancreat Disord Ther. 2012 Dec 6;2(4):1000e128. doi: 10.4172/2165-7092.1000e128. Pancreat Disord Ther. 2012. PMID: 23378937 Free PMC article. No abstract available.
-
Prediction of heterogeneous differential genes by detecting outliers to a Gaussian tight cluster.BMC Bioinformatics. 2013 Mar 5;14:81. doi: 10.1186/1471-2105-14-81. BMC Bioinformatics. 2013. PMID: 23497043 Free PMC article.
-
Lipocalin 2 decreases senescence of bone marrow-derived mesenchymal stem cells under sub-lethal doses of oxidative stress.Cell Stress Chaperones. 2014 Sep;19(5):685-93. doi: 10.1007/s12192-014-0496-5. Epub 2014 Jan 23. Cell Stress Chaperones. 2014. PMID: 24452457 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials